{"id":"lenali","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Constipation","drugRate":"","severity":"common","organSystem":""},{"effect":"Peripheral edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Neutropenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"33%","severity":"common","organSystem":""},{"effect":"Back pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Asthenia","drugRate":"28%","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Infection","drugRate":"75%","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Pneumonia","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Hypokalemia","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Rash","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Cataract","drugRate":"9.6%","severity":"Grade 3/4","organSystem":""},{"effect":"Lymphopenia","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Hyperglycemia","drugRate":"","severity":"Grade 3/4","organSystem":""},{"effect":"Leukopenia","drugRate":"","severity":"Grade 3/4","organSystem":""}],"contraindications":["Breastfeeding (mother)","Chemotherapy-Induced Hyperuricemia","Deep venous thrombosis","Impaired renal function disorder","Neutropenic disorder","Pregnancy, function","Primary malignant neoplasm","Pulmonary thromboembolism","Thrombocytopenic disorder","Thromboembolic disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Infection","drugRate":"28.8%","severity":"serious"},{"effect":"DVT","drugRate":"","severity":"serious"},{"effect":"Pneumonia","drugRate":"","severity":"serious"},{"effect":"Asthenia","drugRate":"8%","severity":"serious"},{"effect":"Fatigue","drugRate":"7%","severity":"serious"},{"effect":"Neutropenia","drugRate":"","severity":"serious"},{"effect":"Thrombocytopenia","drugRate":"","severity":"serious"},{"effect":"Anemia","drugRate":"","severity":"serious"},{"effect":"Dyspnea","drugRate":"","severity":"serious"},{"effect":"Hyperglycemia","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"76f6c1e7-985b-43d9-892c-849df50ae80e","title":"LENALIDOMIDE CAPSULE [MYLAN PHARMACEUTICALS INC.]"},"ecosystem":[],"mechanism":{"target":"Bromodomain-containing protein 4, Protein cereblon, Tumor necrosis factor"},"_scrapedAt":"2026-03-28T02:41:56.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Follicular lymphoma","diseaseId":"follicular-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mantle cell lymphoma","diseaseId":"mantle-cell-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Marginal zone lymphoma","diseaseId":"marginal-zone-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Multiple myeloma","diseaseId":"multiple-myeloma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myelodysplastic syndrome","diseaseId":"myelodysplastic-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03054532","phase":"PHASE2","title":"Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2017-07","conditions":"LYMPHOMA","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Lenali","genericName":"Lenali","companyName":"Singapore General Hospital","companyId":"singapore-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}